Search clinical trials for: High dose melphalan therapy and autologous stem cell transplant (intensive pathway only)
Total 133 results
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Otsuka America PharmaceuticalCompletedNon-Hodgkin's Lymphoma | CNS LymphomaUnited States
-
Samsung Medical CenterKSPNO stem cell transpantation committeeUnknownBrain TumorKorea, Republic of
-
Jaslok Hospital and Research CentreTerminated
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
Burnasyan Federal Medical Biophysical CenterUnknownNeutropenic Enterocolitis | Myeloablative Chemotherapy Induced Bone Marrow AplasiaRussian Federation
-
Stanford UniversityCompletedGraft vs Host Disease | Blood and Marrow Transplant (BMT)United States
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
Washington University School of MedicineTerminated
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.Completed
-
BioInvent International ABTerminatedA Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
St. Jude Children's Research HospitalUniversity of MiamiCompletedNeuroblastoma | Central Nervous System Tumors | Wilms Tumor | LymphomasUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); GlaxoSmithKlineCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Northwestern UniversityUniversity of Sao Paulo General HospitalWithdrawnDiabetes Mellitus, Type 1
-
Acrotech Biopharma Inc.Clinipace Worldwide; Beckloff Associates, Inc.; Kansas City Bioanalytical LaboratoriesCompletedMultiple MyelomaUnited States
-
French Innovative Leukemia OrganisationAmgenCompleted
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; SmithKline BeechamCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
French Innovative Leukemia OrganisationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
University of ArkansasBristol-Myers Squibb; Altor BioScienceWithdrawnMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterCompletedBreast Cancer | Invasive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterCompletedMultiple Myeloma | Primary AmyloidosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Recruiting
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; University of Washington; H. Lee...Active, not recruiting
-
WiSP Wissenschaftlicher Service Pharma GmbHCompleted
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted
-
Medical College of WisconsinUnknownLymphoma | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnEwing Sarcoma of Bone | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Adult Supratentorial Primitive Neuroectodermal Tumor (PNET) and other conditionsUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultiple MyelomaUnited States, Canada
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Aaron EtraRecruiting
-
Institute of Hematology & Blood Diseases HospitalUnknownMultiple Myeloma | Plasma Cell Leukemia | Extramedullary Plasmacytoma | Loss of Chromosome 17p | t(14;16) | t(4;14) | Complex Karyotype | T(14;20) | 1Q21 AmplificationChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndromes | LeukemiaUnited States
-
University of Michigan Rogel Cancer CenterMedical College of WisconsinCompletedPhase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple MyelomaMultiple MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Completed
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)Completed
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...UnknownTesticular Germ Cell Tumor | Brain and Central Nervous System Tumors | Extragonadal Germ Cell TumorItaly